News Center

• Sep. 28

  2023

  CSPC present the results of two latest clinical trials of two investigational products in this ESMO Congress

• Sep. 28

  2023

  CSPC Once Again Listed in China's Top 500 Private Enterprises

• Aug. 30

  2023

  VOLUNTARY ANNOUNCEMENT - SEMAGLUTIDE INJECTION OBTAINS CLINICAL TRIAL APPROVAL

• Aug. 25

  2023

  VOLUNTARY ANNOUNCEMENT - SACUBITRIL VALSARTAN SODIUM TABLETS OBTAINS DRUG REGISTRATION APPROVAL

• Aug. 23

  2023

  VOLUNTARY ANNOUNCEMENT - STRATEGIC COLLABORATION AGREEMENTS IN THE FIELD OF ARTIFICIAL INTELLIGENCE (AI) IN INNOVATIVE DRUG RESEARCH AND DEVELOPMENT

• Aug. 23

  2023

  VOLUNTARY ANNOUNCEMENT - NBL-028 FOR THE TREATMENT OF CLDN6 EXPRESSING ADVANCED TUMORS OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S.